Oral formulations of thr-beta agonist

TW202635312APending Publication Date: 2026-09-01ALIGOS THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114139129
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-11
Filing Date
2025-10-09
Publication Date
2026-09-01

Smart Images

  • Figure TWG2TA001074355_001
    Figure TWG2TA001074355_001
  • Figure TWG2TA001074355_002
    Figure TWG2TA001074355_002
  • Figure TWG2TA001074355_003
    Figure TWG2TA001074355_003
Patent Text Reader

Abstract

Disclosed herein are pharmaceutical compositions comprising a compound of Formula I: or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, and one or more surfactants, and methods of treating disease by administering or contacting a subject with one or more of the above pharmaceutical compositions.
Need to check novelty before this filing date? Find Prior Art